Researchers at The University of Texas MD Anderson Cancer Center have developed a bioinformatics platform that predicts optimal treatment combinations for a given group of patients based on co-occurring tumor alterations. In retrospective validation studies, the tool selected combinations that resulted in improved patient outcomes across both pre-clinical and clinical studies.
Elbert Y. Kuo, a thoracic surgeon who specializes in minimally invasive techniques, has joined Baptist MD Anderson Cancer Center as head of the Division of Surgery and surgeon-in-chief.
